Please login to the form below

Not currently logged in
Email:
Password:

Premier Research appoints Dr Colin Hayward as European medical director

He will lead the company's European medical affairs and pharmacovigilance operations

US pharma services company Premier Research has appointed Dr Colin Hayward to lead and develop its European medical affairs and pharmacovigilance operations.

He joins the Philadelphia-headquartered firm as European medical director from pharmaceutical medicine consultancy Prism Ideas where he served as director.

Prior to that role, Dr Hayward served at Roche, where he held a series of positions in pharmacovigilance leading up to that of international medical leader. Before that he worked in the UK's NHS in anaesthesia and intensive care.

"Dr Hayward brings medical expertise, clinical knowledge, leadership, and a wealth of experience in key areas important to our customers and will provide an added level of therapeutic insight to Premier's services," said Sue Stansfield, executive vice president, clinical development.

"He will be a tremendous asset for both employees and customers and is a welcome addition to our strong team in Europe."

Stansfield herself also joined Premier Research in January, and in her new role will have global responsibility for leading the company's clinical trial management services.

She has more than 25 years experience in the pharmaceutical and contract research industries, including stints at clinical service organisations PRA, PPD and Quintiles.

25th January 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics